2 results match your criteria: "LEPRA Society-Blue Peter Public Health and Research Centre (BPHRC)[Affiliation]"
Robust contact tracing and screening needed for leprosy control and protection of vulnerable children.
Iran J Microbiol
October 2024
Department of Microbiology, LEPRA Society - Blue Peter Public Health and Research Centre (BPHRC), Cherlapally, Hyderabad, India.
Article Synopsis
- A seven-year-old boy from Telangana, India, was diagnosed with borderline-borderline multibacillary leprosy and had a family history of the disease, highlighting active transmission in the community.
- The child exhibited multiple anesthetic skin lesions and enlarged ulnar nerves, which are characteristic symptoms of leprosy.
- Treatment included weight-adjusted multidrug therapy and corticosteroids, underscoring the importance of early detection and contact tracing to avoid complications and potential disabilities in affected children.
Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
PLoS Negl Trop Dis
October 2020
Clinical and Laboratory Research Division, LEPRA Society-Blue Peter Public Health and Research Centre (BPHRC), Hyderabad, India.
Erythema nodosum leprosum (ENL), or type 2 lepra reaction, is a multi-system immune-mediated complication in patients with multibacillary leprosy, frequently associated with chronicity and recurrences. Management of ENL requires high doses of oral corticosteroids, which may not be universally effective and pose serious adverse effects. Thalidomide has proven to be a steroid-sparing agent and is useful in controlling the reactions.
View Article and Find Full Text PDF